BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3953616)

  • 1. Left ventricular dysfunction induced by cold exposure in patients with systemic sclerosis.
    Ellis WW; Baer AN; Robertson RM; Pincus T; Kronenberg MW
    Am J Med; 1986 Mar; 80(3):385-92. PubMed ID: 3953616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cold-induced cardiac abnormalities in systemic sclerosis].
    Rey RH; Marrero G; Chwojnik A; Martínez Martínez J; Maldonado Cocco J; Rodrigué S; Casabé H
    Medicina (B Aires); 1995; 55(4):289-94. PubMed ID: 8728866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of cold challenge responses in primary Raynaud's phenomenon and Raynaud's phenomenon associated with systemic sclerosis.
    O'Reilly D; Taylor L; el-Hadidy K; Jayson MI
    Ann Rheum Dis; 1992 Nov; 51(11):1193-6. PubMed ID: 1466594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left ventricular function at rest and during Raynaud's phenomenon in patients with scleroderma.
    Siegel RJ; O'Connor B; Mena I; Criley JM
    Am Heart J; 1984 Dec; 108(6):1469-76. PubMed ID: 6507243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac Raynaud's phenomenon induced by cold provocation as a predictor of long-term left ventricular dysfunction and remodelling in systemic sclerosis: 7-year follow-up study.
    Mizuno R; Fujimoto S; Saito Y; Nakamura S
    Eur J Heart Fail; 2010 Mar; 12(3):268-75. PubMed ID: 20071354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of intravenous infusions of iloprost and oral nifedipine in treatment of Raynaud's phenomenon in patients with systemic sclerosis: a double blind randomised study.
    Rademaker M; Cooke ED; Almond NE; Beacham JA; Smith RE; Mant TG; Kirby JD
    BMJ; 1989 Mar; 298(6673):561-4. PubMed ID: 2467711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cold-induced coronary Raynaud's phenomenon in patients with systemic sclerosis.
    Lekakis J; Mavrikakis M; Emmanuel M; Prassopoulos V; Papazoglou S; Papamichael C; Moulopoulou D; Kostamis P; Stamatelopoulos S; Moulopoulos S
    Clin Exp Rheumatol; 1998; 16(2):135-40. PubMed ID: 9536388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute estrogen administration can reverse cold-induced coronary Raynaud's phenomenon in systemic sclerosis.
    Lekakis J; Mavrikakis M; Emmanuel M; Prassopoulos V; Papamichael C; Moulopoulou D; Ziaga A; Kostamis P; Moulopoulos S
    Clin Exp Rheumatol; 1996; 14(4):421-4. PubMed ID: 8871843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations of glomerular filtration rate during cold exposure in progressive systemic sclerosis: measurement with technetium-99m DTPA.
    Yamauchi K; Arimori S
    Jpn J Med; 1990; 29(2):208-11. PubMed ID: 2232369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of diltiazem on cold-induced left ventricular dysfunction in patients with systemic sclerosis].
    Rey RH; Marrero G; Chwojnik A; Martínez Martínez JA; Maldonado Cocco J; Rodrigué S; Casabé H
    Medicina (B Aires); 1997; 57(1):47-51. PubMed ID: 9435369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reproducibility of cold provocation in patients with Raynaud's phenomenon.
    Wigley FM; Malamet R; Wise RA
    J Rheumatol; 1987 Aug; 14(4):751-5. PubMed ID: 3668980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nifedipine in primary Raynaud's phenomenon and in scleroderma: oral versus sublingual hemodynamic effects.
    Wollersheim H; Thien T; van 't Laar A
    J Clin Pharmacol; 1987 Nov; 27(11):907-13. PubMed ID: 3429697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversible myocardial perfusion defects during cold challenge in scleroderma.
    Long A; Duffy G; Bresnihan B
    Br J Rheumatol; 1986 May; 25(2):158-61. PubMed ID: 3708232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cold stimulus fingertip lacticemy test--an effective method to monitor acute therapeutic intervention on primary Raynaud's phenomenon and systemic sclerosis.
    Fontenelle SM; Kayser C; Pucinelli ML; Andrade LE
    Rheumatology (Oxford); 2008 Jan; 47(1):80-3. PubMed ID: 18077495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the cold pressor test on diffusing capacity. Comparison of normal subjects and those with Raynaud's disease and progressive systemic sclerosis.
    Miller MJ
    Chest; 1983 Sep; 84(3):264-6. PubMed ID: 6884100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term effect of cold provocation on single-breath carbon monoxide diffusing capacity in subjects with and without Raynaud's phenomenon.
    Gastaud M; Dolisi C; Bermon S; Gaudin P; Defauw G; Ardisson JL
    Clin Exp Rheumatol; 1995; 13(5):617-21. PubMed ID: 8575140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of nifedipine in Raynaud's phenomenon associated with systemic sclerosis.
    Thakur SK; Gopinathan VP; Jagdish TK; Bhalla IP; Shetty KJ
    J Assoc Physicians India; 1986 Jul; 34(7):536. PubMed ID: 3759897
    [No Abstract]   [Full Text] [Related]  

  • 18. Local cold exposure test with a new arterial photoplethysmographic sensor in healthy controls and patients with secondary Raynaud's phenomenon.
    Hahn M; Hahn C; Jünger M; Steins A; Zuder D; Klyscz T; Büchtemann A; Rassner G; Blazek V
    Microvasc Res; 1999 Mar; 57(2):187-98. PubMed ID: 10049666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Responses to nifedipine by patients with Raynaud's disease and Raynaud's phenomenon secondary to another disease.
    Riccio A; Del Puente A; Farinaro C; Scarpa R; Oriente P; Rocco P; Gioia M
    Clin Ther; 1987; 9(2):232-7. PubMed ID: 3568066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversible cold-induced abnormalities in myocardial perfusion and function in systemic sclerosis.
    Alexander EL; Firestein GS; Weiss JL; Heuser RR; Leitl G; Wagner HN; Brinker JA; Ciuffo AA; Becker LC
    Ann Intern Med; 1986 Nov; 105(5):661-8. PubMed ID: 3767147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.